Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B

Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B

Two of the main pathologies characterizing dysferlinopathies are disrupted muscle membrane repair and chronic inflammation, which lead to symptoms of muscle weakness and wasting. Here, we used recombinant human Galectin-1 (rHsGal-1) as a therapeutic for LGMD2B mouse and human models. Various redox a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mary L. Vallecillo-Zúniga, Peter Daniel Poulson, Jacob S. Luddington, Christian J. Arnold, Matthew Rathgeber, Braden C. Kartchner, Spencer Hayes, Hailie Gill, Jonard C. Valdoz, Jonathan L. Spallino, Seth Garfield, Ethan L. Dodson, Connie M. Arthur, Sean R. Stowell, Pam M. Van Ry
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Galectin-1
LGMD2B
membrane repair
NF-ĸB
inflammation
cytokines
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/91776f7c4f7e4124ac9a89b01315ee53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/91776f7c4f7e4124ac9a89b01315ee53

Ejemplares similares